By: Russell Phillips
If it’s a pump, then where’s the tubing? Well, it looks like another company has put a patch on that problem. Medingo Ltd., a company held by Elron Electronic Industries, has received FDA approval to market the Solo MicroPump Insulin Delivery System. The Solo System consists of an insulin-dispensing patch and a remote control device that increases or decreases the patch’s rate of secretion.
According to the Medingo website, “the Solo Insulin Dispensing Patch is the smallest, thinnest, lightest, most discreet insulin pump without cumbersome tubing.” It’s easy to insert, and it can be disconnected any time without losing insulin. It boluses with patch buttons even when the remote is not handy, and there’s a smart “Bolus Guide” inside. Advanced safety features like an occlusion sensor and safety alerts are part of the package. Reportedly, the upfront cost is not too high. You can pay as you go, it’s reimbursable, and there is no long-term commitment. The remote even comes in a variety of colors.
The only other patch pump on the market currently is the OmniPod from Insulet. To learn more about how another form of patch pump works, read The U-Strip: A Proposed Pump in a Patch